INNOLABS Seminar/Web Seminar: How to design and run a clinical trial?

11:00 bis 14:00 Uhr
Kalendereintrag speichern
Berlin Partner für Wirtschaft und Technologie GmbH

Fasanenstr. 85

10623 Berlin


Are you planning to run a clinical trial and are still looking for expert guidance in trial design? The second episode of our lunch seminars focuses on clinical evidence.

REGISTER for a lunch seminar and opportunity to network and exchange experiences of CLINICAL TRIAL DESIGN.

July 16th 2019 | 11:00-14:00

Berlin Partner is hosting a seminar on clinical evidence with focus on how to design and run a clinical trial.

The seminar will be also web-streamed and recorded. Followed by a 2hrs presentation a lunch will be served and you'll have the opportunity to network and exchange experiences.

We have invited Uwe Anzenberger from LINK Medical. As Country Manager he focuses on supporting SMEs to develop their products (Medical devices and Pharma/Biotech) from idea to market. He gained expert knowledge into the regulatory and clinical development of pharmaceutical and biotechnological compounds at PAREXEL and in 2015 he joined LINK Medical. He is technical Biologist and obtained his doctorate with honors in the area of developmental biology, as he established an animal model to elucidate the function of a specific protein in the vertebrate forebrain development at the Max-Delbrück-Center of Molecular Medicine in Berlin.


Please send an email including the names of participants to:


The seminar will be also web-streamed and recorded. The link will be provided to registered participants one day prior to the event.


This event is organzied within the EU funded project INNOLABS:

INNOLABS is leveraging cross capacity between ICT, Health, BIO and Medicine sectors for new emerging industries in personalized health. It aims to foster collaboration, transfer of knowledge and opportunities among SMEs from different countries and sectors in order to develop, improve and deliver disruptive technologies mainly related to mHealth, personalized healthcare and ageing populations.